Literature DB >> 20589130

p53 expression in colorectal carcinoma in relation to histopathological features in Ugandan patients.

Peter F Rambau1, Michael Odida, Henry Wabinga.   

Abstract

BACKGROUND: It has been shown that colorectal carcinoma is increasing in incidence in African countries. This could be due to change in life style. Molecular pathogenesis of colorectal cancer commonly involves mutation in p53 gene which leads to expression of p53 protein in tumor cells. Expression of p53 protein has been associated with poor clinical outcome and reduced survival in patients.
OBJECTIVE: This was a retrospective laboratory based study carried out in the Department of Pathology Makerere University, Kampala, Uganda. The aim of the study was to evaluate the expression of p53 protein in colorectal carcinoma in Ugandan patients, specifically its association with histological types, degree of differentiation, sites of the tumor and demographic characteristics of the patients.
METHODS: Immunohistochemistry was carried out on 109 patient's paraffin embedded tissue blocks of colorectal carcinoma diagnosed in the Pathology Department, Faculty of Medicine Makerere University Kampala during the period 1995 to 2005. The indirect immunoperoxidase method using monoclonal antibody p53 DO-7 and Envision (+) Dual link system-HRP to detect p53 expression was used. Haematoxylin and eosin stain was used for evaluation of histological types and degree of differentiation of the tumors. Topography of the tumors and demographic data were obtained from accompanying histological request forms.
RESULTS: Out of 109 patient's tissue blocks that were studied, 61 cases (56%) expressed p53 protein in the nucleus of malignant cells. Right sided colonic tumors were commoner (53.2%) than left sided colonic tumors (46.8%). p53 protein was expressed more in left sided colonic tumors with a significant difference (p<0.05), it was also expressed more in well differentiated tumors and non mucinous adenocarcinomas but with no significant difference (p>0.05). p53 expression was not affected by age or sex.
CONCLUSION: Frequency of p53 protein expression in Ugandan patients did not differ from that reported in the other parts of the world. It was expressed more in the left sided colonic tumors and this could support the hypothesis that right and left colonic tumors could have different pathogenesis and probably also responsible for difference in prognosis in these two topographic sites.

Entities:  

Keywords:  Immunohistochemistry; colorectal carcinoma; p53

Mesh:

Substances:

Year:  2008        PMID: 20589130      PMCID: PMC2887007     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  28 in total

1.  P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.

Authors:  H Elsaleh; B Powell; K McCaul; F Grieu; R Grant; D Joseph; B Iacopetta
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

2.  Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.

Authors: 
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

3.  Different p53 mutation patterns in colorectal tumors from smokers and nonsmokers.

Authors:  Chi-Chou Huang; Ya-Wen Cheng; Meng-Cheng Chen; Yu-Shyang Lin; Ming-Chih Chou; Huei Lee
Journal:  Environ Mol Mutagen       Date:  2006-08       Impact factor: 3.216

4.  Mechanisms of oncogenesis in colon versus rectal cancer.

Authors:  E Kapiteijn; G J Liefers; L C Los; E K Kranenbarg; J Hermans; R A Tollenaar; Y Moriya; C J van de Velde; J H van Krieken
Journal:  J Pathol       Date:  2001-09       Impact factor: 7.996

5.  p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.

Authors:  H Bouzourene; P Gervaz; J P Cerottini; J Benhattar; P Chaubert; E Saraga; S Pampallona; F T Bosman; J C Givel
Journal:  Eur J Cancer       Date:  2000-05       Impact factor: 9.162

6.  p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women.

Authors:  K Servomaa; A Kiuru; V M Kosma; P Hirvikoski; T Rytömaa
Journal:  Mol Pathol       Date:  2000-02

7.  p53 protein accumulation and p53 gene mutation in colorectal cancer.

Authors:  A Nasierowska-Guttmejer ; L Trzeciak ; M P Nowacki ; J Ostrowski
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

8.  Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trials.

Authors:  James J Dignam; Yunrong Ye; Linda Colangelo; Roy Smith; Eleftherios P Mamounas; H Samuel Wieand; Norman Wolmark
Journal:  J Clin Oncol       Date:  2003-02-01       Impact factor: 44.544

9.  Fighting colorectal cancer: molecular epidemiology differences among Ashkenazi and Sephardic Jews and Palestinians.

Authors:  H Darwish; I E Trejo; I Shapira; S Oweineh; M Sughayer; L Baron; E Aljadeff; M Silbermann; W Sweidan; D Zilberg; Z Halpern; H Hibshoosh; N Arber
Journal:  Ann Oncol       Date:  2002-09       Impact factor: 32.976

10.  Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?

Authors:  Viviana Bazan; Manuela Migliavacca; Carla Tubiolo; Marcella Macaluso; Ines Zanna; Simona Corsale; Antonella Amato; Valentina Calò; Gabriella Dardanoni; Vincenza Morello; Mario La Farina; Ida Albanese; Rosa Maria Tomasino; Nicola Gebbia; Antonio Russo
Journal:  J Cell Physiol       Date:  2002-05       Impact factor: 6.384

View more
  5 in total

1.  The roles of p53 and XPO1 on colorectal cancer progression in Yemeni patients.

Authors:  Mohammed Aladhraei; Eman Al-Salami; Naravat Poungvarin; Prasit Suwannalert
Journal:  J Gastrointest Oncol       Date:  2019-06

2.  Colorectal cancer in patients seen at the teaching hospitals of Guadeloupe and Martinique: discrepancies, similarities in clinicopathological features, and p53 status.

Authors:  Monique Decastel; Marlene Ossondo; Anne-Marie Andrea; Benoît Tressieres; Jacqueline Veronique-Baudin; Jacqueline Deloumeaux; Marc Lubeth; Juliette Smith-Ravin
Journal:  BMC Clin Pathol       Date:  2014-03-29

3.  Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer.

Authors:  Xian Hua Gao; Guan Yu Yu; Hai Feng Gong; Lian Jie Liu; Yi Xu; Li Qiang Hao; Peng Liu; Zhi Hong Liu; Chen Guang Bai; Wei Zhang
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

4.  Screening and Identification of Differentially Expressed Genes Expressed among Left and Right Colon Adenocarcinoma.

Authors:  Jing Han; Xue Zhang; Yang Yang; Li Feng; Gui-Ying Wang; Nan Zhang
Journal:  Biomed Res Int       Date:  2020-01-21       Impact factor: 3.411

5.  Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods.

Authors:  Yimei Jiang; Xiaowei Yan; Kun Liu; Yiqing Shi; Changgang Wang; Jiele Hu; You Li; Qinghua Wu; Ming Xiang; Ren Zhao
Journal:  BMC Cancer       Date:  2020-10-19       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.